Development and characterization of bio-derived polyhydroxyalkanoate nanoparticles as a delivery system for hydrophobic photodynamic therapy agents

Journal of Materials Science: Materials in Medicine

Volumn 27, Issue 2, 2016, Pages 1-11

  Pramual, Sasivimon ^a   Assavanig, Apinya ^a   Bergkvist, Magnus ^b   Batt, Carl A ^c   Sunintaboon, Panya ^a   Lirdprapamongkol, Kriengsak ^d   Svasti, Jisnuson ^a,d   Niamsiri, Nuttawee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SUNY POLYTECHNIC INSTITUTE   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d Krung Thep Maha Nakhon   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DEATH; EMULSIFICATION; HYDROPHOBICITY; NANOPARTICLES; NANOTECHNOLOGY; PHOTOSENSITIZERS; POLYVINYL ALCOHOLS;

CONCENTRATION-DEPENDENT; EMULSIFICATION-DIFFUSION METHODS; HYDRODYNAMIC DIAMETER; NARROW SIZE DISTRIBUTIONS; PHOTODYNAMIC THERAPY (PDT); POLY (VINYL ALCOHOL) (PVA); POLY(HYDROXYBUTYRATE- CO-HYDROXYVALERATE); SPHERICAL MORPHOLOGIES;

PHOTODYNAMIC THERAPY;

5,10,15,20 TETRAKIS(4 HYDROXY PHENYL) 21H,23H PORPHINE; DRUG CARRIER; NANOPARTICLE; PHOTOSENSITIZING AGENT; POLY(HYDROXYBUTYRATE CO HYDROXYVALERATE); POLYHYDROXYALKANOIC ACID; POLYHYDROXYBUTYRATE; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG; 5,10,15,20-TETRA(4-HYDROXYPHENYL)PORPHYRIN; BIOLOGICAL PRODUCT; EXCIPIENT; PORPHYRIN;

ARTICLE; CELL DEATH; CONTROLLED STUDY; DIFFUSION; DRUG RELEASE; EMULSIFICATION DIFFUSION METHOD; EMULSION; ENCAPSULATION; HT 29 CELL LINE; HUMAN; HUMAN CELL; HYDRODYNAMICS; HYDROPHOBICITY; IN VITRO STUDY; PARTICLE SIZE; PHOTOCYTOTOXICITY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; CHEMICAL PHENOMENA; CHEMISTRY; CUPRIAVIDUS NECATOR; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; HT-29 CELL LINE; MATERIALS TESTING; PHOTOCHEMOTHERAPY; PROCEDURES; SYNTHESIS;

BIOLOGICAL PRODUCTS; CUPRIAVIDUS NECATOR; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; HT29 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MATERIALS TESTING; NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYHYDROXYALKANOATES; POLYVINYL ALCOHOL; PORPHYRINS;

EID: 84951870729     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-015-5655-4     Document Type: Article

References (67)

1. Schuitmaker JJ, Baas P, Leengoed HLLM, Meulen FW, Star WM, Zandwijk N. Photodynamic therapy: a promising new modality for the treatment of cancer. J Photochem Photobiol B, Biol. 1996;34:3–12.
2. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1:212–9.
3. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497–508.
4. Hopper C, Kubler A, Lewis H, Tan IB, Putnam G. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer. 2004;111:138–46.
5. Molinari A, et al. m-THPC-mediated photodynamic therapy of malignant gliomas: assessment of a new transfection strategy. Int J Cancer. 2007;121:1149–55.
6. Zimmermann A, Ritsch-Marte M, Kostron H. mTHPC-mediated photodynamic diagnosis of malignant brain tumors. Photochem Photobiol. 2001;74:611–6.
7. O’Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol. 2009;85:1053–74.
8. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145–57.
9. Berg K, et al. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J Microsc. 2005;218:133–47.
10. Kostron H, Bellnier DA, Lin CW, Swartz MR, Martuza RL. Distribution, retention, and phototoxicity of hematoporphyrin derivative in a rat glioma. J Neurosurg. 1986;64:768–74.
11. Taquet JP, Frochot C, Manneville V, Barberi-Heyob M. Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy. Curr Med Chem. 2007;14:1673–87.
12. Bechet D, Couleaud P, Frochot C, Viriot ML, Guillemin F, Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 2008;26:612–21.
13. Pavani C, Uchoa AF, Oliveira CS, Iamamoto Y, Baptista MS. Effect of zinc insertion and hydrophobicity on the membrane interactions and PDT activity of porphyrin photosensitizers. Photochem Photobiol Sci. 2009;8:233–40.
14. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55:329–47.
15. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387–92.
16. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995;55:3752–6.
17. Konan-Kouakou YN, Boch R, Gurny R, Allemann E. In vitro and in vivo activities of verteporfin-loaded nanoparticles. J Control Release. 2005;103:83–91.
18. Zeisser-Labouebe M, Lange N, Gurny R, Delie F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm. 2006;326:174–81.
19. Hu Z, Pan Y, Wang J, Chen J, Li J, Ren L. Meso-tetra (carboxyphenyl) porphyrin (TCPP) nanoparticles were internalized by SW480 cells by a clathrin-mediated endocytosis pathway to induce high photocytotoxicity. Biomed Pharmacother. 2009;63:155–64.
20. Ungun B, Prud’homme RK, Budijon SJ, Shan J, Lim SF, Ju Y, Austin R. Nanofabricated upconversion nanoparticles for photodynamic therapy. Opt Express. 2009;17:80–6.
21. Anderson AJ, Dawes EA. Occurrence, metabolism, metabolic role, and industrial use of bacterial polyhydroxyalkanoates. Microbiol Rev. 1990;54:450–72.
22. Lee EY, Kang SH, Choi CY. Biosynthesis of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) by newly isolated Agrobacterium sp. SH-1 and GW-014 from structurally unrelated single carbon substrates. J Ferment Bioeng. 1995;79:328–34.
23. Verlinden RAJ, Hill DJ, Kenward MA, Williams CD, Radecka I. Bacterial synthesis of biodegradable polyhydroxyalkanoates. J Appl Microbiol. 2007;102:1437–49.
24. Chanprateep S. Current trends in biodegradable polyhydroxyalkanoates. J Biosci Bioeng. 2010;110:621–32.
25. Duran N, Alvarenga MA, Da Silva EC, Melo PS, Marcato PD. Archives of microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate). Arch Pharm Res. 2008;31:1509–16.
26. Vilos C, Constandil L, Herrera N, Solar P, Escobar-Fica J, Velasquez L. Ceftiofur-loaded PHBV microparticles: a potential formulation for a long-acting antibiotic to treat animal infections. Electron J Biotechnol. 2012;15:1–13.
27. Grillo R, et al. Controlled release system for ametryn using polymer microspheres: preparation, characterization and release kinetics in water. J Hazard Mater. 2011;186:1645–51.
28. Lee J, Jung SG, Park CS, Kim HY, Batt CA, Kim YR. Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer. Bioorg Med Chem Lett. 2011;21:2941–4.
29. Masood F, Chen P, Yasin T, Fatima N, Hasan F, Hameed A. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. Mater Sci Eng C Mater. 2013;33:1054–60.
30. Vilos C, et al. Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials. 2013;34:4098–108.
31. Bonnett R, McGarvey DJ, Harriman A, Land EJ, Truscott TG, Winfield UJ. Photophysical properties of meso-tetraphenylporphyrin and some meso-tetra (hydroxyphenyl) porphyrins. Photochem Photobiol. 1988;48:271–6.
32. Nawalany K, et al. Novel nanostructural photosensitizers for photodynamic therapy: in vitro studies. Int J Pharm. 2012;430:129–40.
33. Berenbaum MC, Akande SL, Bonnett R, Kaur H, Ioannou S, White RD, Winfield UJ. meso-Tetra (hydroxyphenyl) porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer. 1986;54:717–25.
34. Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra (hydroxyphenyl) porphyrin series as tumour photosensitizers. Biochem J. 1989;261:277–80.
35. Gomer CJ. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol. 1991;54:1093–107.
36. Kepczynski M, Nawalany K, Kumorek M, Kobierska A, Jachimska B, Nowakowska M. Which physical and structural factors of liposome carriers control their drug-loading efficiency? Chem Phys Lipids. 2008;155:7–15.
37. Shang L, Yim SC, Park HG, Chang HN. Sequential feeding of glucose and valerate in a fed-batch culture of Ralstonia eutropha for production of poly(hydroxybutyrate-co-hydroxyvalerate) with high 3-hydroxyvalerate fraction. Biotechnol Prog. 2004;20:140–4.
38. Loo CY, Sudesh K. Biosynthesis and native granule characteristics of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) in Delftia acidovorans. Int J Biol Macromol. 2007;40:466–71.
39. Huijberts GNM, van der Wal H, Wilkinson C, Eggink G. Gas-chromatographic analysis of poly(3-hydroxyalkanoates) in bacteria. Biotechnol Tech. 1994;8:187–92.
40. Jacquel N, Lo CW, Wei YH, Wu HS, Wang SS. Isolation and purification of bacterial poly(3-hydroxyalkanoates). Biochem Eng J. 2008;39:15–27.
41. de Mello VA, Ricci-Junior E. Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies. Quim Nova. 2011;34:933–9.
42. Averineni RK, et al. PLGA 50:50 nanoparticles of paclitaxel: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation. Bull Mater Sci. 2012;35:319–26.
43. Konan YN, Gurny R, Allemann E. Preparation and characterization of sterile and freeze-dried sub-200nm nanoparticles. Int J Pharm. 2002;233:239–52.
44. Konan YN, Cerny R, Favet J, Berton M, Gurny R, Allemann E. Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm. 2003;55:115–24.
45. Yoshimoto AN, et al. Hedgehog pathway signaling regulates human colon carcinoma HT-29 epithelial cell line apoptosis and cytokine secretion. PLoS One. 2012;7:e45332.
46. Lirdprapamongkol K, Kramb JP, Suthiphongchai T, Surarit R, Srisomsap C, Dannhardt G, Svasti J. Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in vivo. J Agric Food Chem. 2009;57:3055–63.
47. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharm Rev. 2001;53:283–318.
48. Quintanar-Guerrero D, Fessi H, Allemann E, Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm. 1996;143:133–41.
49. Poletto FS, Fiel LA, Donida B, Re MI, Guterres SS, Pohlmann AR. Controlling the size of poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles prepared by emulsification-diffusion technique using ethanol as surface agent. Colloids Surf Physicochem Eng Asp. 2008;324:105–12.
50. Shaffie KA, Moustafa AB, Saleh NH, Nasr HE. Effect of polyvinyl alcohol of different molecular weights as protective colloids on the kinetics of the emulsion polymerization of vinyl acetate. J Am Sci. 2010;6:1202–12.
51. Manangana T, Shawaphuna S. Quantitative extraction and determination of polyhydroxyalkanoate accumulated in Alcaligenes latus dry cells. Sci Asia. 2010;36:199–203.
52. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82:105–14.
53. Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R, Puglisi G. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm. 2006;325:172–9.
54. Choi GG, Kim HW, Rhee YH. Enzymatic and non-enzymatic degradation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolyesters produced by Alcaligenes sp. MT-16. J Microbiol. 2004;42:346–52.
55. Asrar J, Valentin HE, Berger PA, Tran M, Padgette SR, Garbow JR. Biosynthesis and properties of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) polymers. Biomacromolecules. 2002;3:1006–12.
56. Prabha S, Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm Res. 2004;21:354–64.
57. Zunszain PA, Ghuman J, Komatsu T, Tsuchida E, Curry S. Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct Biol. 2003;7:3–6.
58. Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5:23–36.
59. Siepmann J, Peppas NA. Higuchi equation: derivation, applications, use and misuse. Int J Pharm. 2011;418:6–12.
60. Bhosale UV, Devi K, Choudhary S. Development and in vitro-in vivo evaluation of oral drug delivery system of acyclovir loaded PLGA nanoparticles. Int J Drug Deliv. 2013;5:331–43.
61. Nawalany K, et al. Comparison of photodynamic efficacy of tetraarylporphyrin pegylated or encapsulated in liposomes: in vitro studies. J Photochem Photobiol B Biol. 2009;97:8–17.
62. Murueva AV, Shishatskaya EI, Kuzmina AM, Volova TG, Sinskey AJ. Microparticles prepared from biodegradable polyhydroxyalkanoates as matrix for encapsulation of cytostatic drug. J Mater Sci Mater Med. 2013;24:1905–15.
63. Konan YN, Berton M, Gurny R, Allemann E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200nm nanoparticles. Eur J Pharm Sci. 2003;18:241–9.
64. Pouton CW, Majid MIA, Natarianni LJ. Degradation of polyhydroxbutyrate and related copolymers. Proc Int Symp Control Release Bioact Mater. 1988;15:181–3.
65. Holland SJ, Yasin M, Tighe B. Polymers for biodegradable medical devices VII. Hydroxy butyrate-hydroxyvalerate copolymers: degradation of copolymers and their blends with polysaccharides under in vitro physiological conditions. Biomaterials. 1990;11:206–15.
66. Vargas A, et al. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int J Pharm. 2004;286:131–45.
67. Lee DJ, et al. Multifunctional poly (lactide-co-glycolide) nanoparticles for luminescence/magnetic resonance imaging and photodynamic therapy. Int J Pharm. 2012;434:257–63.